Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore
How fast can Hims & Hers grow without selling GLP-1 drugs? Maybe a lot faster than you think.
📰 Original Source
Read full article at Fool →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.